CUTANEOUS T-CELL LYMPHOMA STAGE IV

This adverse event was reported 36 times

These drugs are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE IV:

# Drug Count
0 DUPILUMAB 24
1 METHOTREXATE SODIUM 4
2 UPADACITINIB 4
3 BARICITINIB 3
4 BEXAROTENE 3
5 METHOTREXATE 3
6 HYDROXYZINE 2
7 INFLIXIMAB 2
8 MECHLORETHAMINE HYDROCHLORIDE 2
9 ALLOPURINOL 1
See all common drugs associated with CUTANEOUS T-CELL LYMPHOMA STAGE IV

CUTANEOUS T-CELL LYMPHOMA STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEXAROTENE 3 0.0023
1 BARICITINIB 3 0.0010
2 MECHLORETHAMINE HYDROCHLORIDE 2 0.0009
3 DESLORATADINE 1 0.0001
4 BENDAMUSTINE HCL 1 0.0001
5 HUMAN IMMUNOGLOBULIN G 1 0.0000
6 UPADACITINIB 4 0.0000
7 DUPILUMAB 24 0.0000
8 HYDROXYZINE 2 0.0000
9 RABEPRAZOLE SODIUM 1 0.0000
See all drugs enriched for association with CUTANEOUS T-CELL LYMPHOMA STAGE IV